Effects of long-term inhaled corticosteroids on adrenal function in patients with asthma

Annals of Allergy, Asthma and Immunology

Volumn 96, Issue 3, 2006, Pages 437-444

  White, Martha ^a,b   Crisalida, Tera ^a,b   Li, Henry ^a,b   Economides, Athena ^a,b   Kaliner, Michael ^a,b  

^a Institute for Asthma and Allergy   (United States)

^b Institute for Asthma and Allergy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZMACORT INHALATION AEROSOL; CORTICOSTEROID; FLOVENT INHALATION AEROSOL; FLUNISOLIDE; FLUTICASONE PROPIONATE; HYDROCORTISONE; TETRACOSACTIDE; TRIAMCINOLONE ACETONIDE;

ADRENAL DISEASE; ADRENAL FUNCTION; ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; RISK FACTOR; TREATMENT DURATION;

EID: 33645231621     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60911-8     Document Type: Article

References (23)

1. Bleecker E. Inhaled corticosteroids: current products and their role in patient care. J Allergy Clin Immunol. 1998;101(2 pt 2):S400-S402.
2. Barnes PJ. Efficacy of inhaled corticosteroids in asthma. J Allergy Clin Immunol. 1998;102:531-538.
3. National Asthma Education and Prevention Program. Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health; July 1997. NIH publication 97-4051.
4. Lipworth BJ, Wilson B. Dose response to inhaled corticosteroids. Semin Respir Crit Care Med. 1998;19:625-646.
5. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch Intern Med. 1999;159:941-955.
6. Nelson HS, Stricker W, Casale TB, et al. A comparison of methods for assessing hypothalamic-pituitary-adrenal (HPA) axis activity in asthma patients treated with inhaled corticosteroids. J Clin Pharmacol. 2002;42:319-326.
7. Fowler SJ, Orr LC, Wilson AM, et al. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate. Br J Clin Pharmacol. 2001;52:93-95.
8. Szefler SJ, Martin RJ, King TS, et al; Asthma Clinical Research Network of the National Heart Lung, and Blood Institute. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol. 2002;109:410-418.
9. Lipworth BJ, Jackson CM. Safety of inhaled and intranasal corticosteroids: lessons for the new millennium. Drug Saf. 2000;23:11-33.
10. National Asthma Education and Prevention Program. Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma-Update on Selected Topics 2002. Bethesda, MD: National Institutes of Health; 2002. NIH publication 02-5075.
11. Allen DB, Bielory L, Derendorf H, et al. Inhaled corticosteroids: past lessons and future issues. J Allergy Clin Immunol. 2003;112(3):S1-40.
12. O'Byrne PM, Pedersen S. Measuring efficacy and safety of different inhaled corticosteroid preparations. J Allergy Clin Immunol. 1998;102:879-886.
13. Wilson AM, McFarlane LC, Lipworth BJ. Effects of low and high doses of inhaled flunisolide and triamcinolone acetonide on basal and dynamic measures of adrenocortical activity in healthy volunteers. J Clin Endocrinol Metab. 1998;83:922-925.
14. Corren J. Intranasal corticosteroids for allergic rhinitis: how do different agents compare? J Allergy Clin Immunol. 1999;104: S144-9.
15. Sheikh S, Goldsmith LJ, Howell L, Eid N. Comparison of the efficacy of inhaled fluticasone propionate, 880 μg/day with flunisolide 1500 μg/day in moderate-to-severe persistent asthma. Ann Allergy Asthma Immunol. 1999;83:300-304.
16. Li JT. Inhaled corticosteroid therapy in asthma: a balancing act. Ann Allergy Asthma Immunol. 1999;82:229-230.
17. Wilson AM, McFarlane LC, Lipworth BJ. Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics. Am J Respir Crit Care Med. 1997;156(4 pt 1):1274-7.
18. Todd GR, Acerini CL, Ross-Russell R, et al. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child. 2002;87:457-461.
19. Drake AJ, Howells RJ, Shield JP, et al. Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate. BMJ. 2002;324:1081-1082.
20. Dunlop KA, Carson DJ, Shields MD. Hypoglycemia due to adrenal suppression secondary to high-dose nebulized corticosteroid. Pediatr Pulmonol. 2002;34:85-86.
21. Dickens GR, Wermeling DP, Matheny CJ, et al. Pharmacokinetics of flunisolide administered via metered dose inhaler with and without a spacer device and following oral administration. Ann Allergy Asthma Immunol. 2000;84:528-532.
22. Kelly HW. Establishing a therapeutic index for the inhaled corticosteroids, part I: pharmacokinetic/pharmacodynamic comparison of the inhaled corticosteroids. J Allergy Clin Immunol. 1998;102(4 pt 2):S36-51.
23. Zimmerman B, Gold M, Wherrett D, Hanna AK. Adrenal suppression in two patients with asthma treated with low doses of the inhaled steroids fluticasone propionate. J Allergy Clin Immunol. 1998;101:425-426.